CID 16133556

5'-d[ggggttgggg]-3' phosphorothioate oligonucleotide

Structural Information

Molecular Formula
C100H123N44O51P9S9
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=O)(OC6CC(OC6COP(=S)(O)OC7CC(OC7CO)N8C=NC9=C8N=C(NC9=O)N)N1C=NC2=C1N=C(NC2=O)N)S)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)O
InChI
InChI=1S/C100H123N44O51P9S9/c1-33-13-135(99(157)133-81(33)147)56-5-37(48(180-56)18-171-200(163,209)191-41-9-61(141-29-113-69-77(141)121-95(105)129-87(69)153)184-52(41)22-175-204(167,213)195-44-12-64(144-32-116-72-80(144)124-98(108)132-90(72)156)185-53(44)23-174-202(165,211)192-40-8-60(140-28-112-68-76(140)120-94(104)128-86(68)152)181-49(40)19-169-197(160,206)187-36-4-58(177-45(36)15-145)138-26-110-66-74(138)118-92(102)126-84(66)150)188-198(161,207)170-17-47-38(6-57(179-47)136-14-34(2)82(148)134-100(136)158)189-199(162,208)172-21-51-42(10-62(183-51)142-30-114-70-78(142)122-96(106)130-88(70)154)193-203(166,212)176-24-54-43(11-63(186-54)143-31-115-71-79(143)123-97(107)131-89(71)155)194-201(164,210)173-20-50-39(7-59(182-50)139-27-111-67-75(139)119-93(103)127-85(67)151)190-196(159,205)168-16-46-35(146)3-55(178-46)137-25-109-65-73(137)117-91(101)125-83(65)149/h13-14,25-32,35-64,145-146H,3-12,15-24H2,1-2H3,(H,159,205)(H,160,206)(H,161,207)(H,162,208)(H,163,209)(H,164,210)(H,165,211)(H,166,212)(H,167,213)(H,133,147,157)(H,134,148,158)(H3,101,117,125,149)(H3,102,118,126,150)(H3,103,119,127,151)(H3,104,120,128,152)(H3,105,121,129,153)(H3,106,122,130,154)(H3,107,123,131,155)(H3,108,124,132,156)
InChIKey
ISVAOBACHFGKMN-UHFFFAOYSA-N
Compound name
1-[5-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-sulfanylphosphoryl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-4-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

3322.3508 Da
Monoisotopic Mass

-7.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3323.3581 301.4
[M+Na]+ 3345.3400 303.2
[M-H]- 3321.3435 301.5
[M+NH4]+ 3340.3846 302.0
[M+K]+ 3361.3140 302.3
[M+H-H2O]+ 3305.3481 301.6
[M+HCOO]- 3367.3490 302.2
[M+CH3COO]- 3381.3647 302.4
[M+Na-2H]- 3343.3255 303.8
[M]+ 3322.3503 303.3
[M]- 3322.3513 303.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.